We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDP
1401
DELISTED
Meredith Corporation
MDP
| $496K | ﹤0.01% |
9,220
+1,135
| +14% | +$67.4K |
|
|
CCRN
1402
DELISTED
Cross Country Healthcare
CCRN
| $494K | ﹤0.01% |
44,434
-60
| -0.1% | -$752 |
|
1403
AZZ Inc
AZZ
$4.41B
| $493K | ﹤0.01% |
11,285
-135
| -1% | -$6.04K |
|
1404
Phibro Animal Health
PAHC
$1.48B
| $492K | ﹤0.01% |
12,402
-3,279
| -21% | -$121K |
|
1405
CONMED
CNMD
$1.33B
| $491K | ﹤0.01% |
7,746
-2,765
| -26% | -$165K |
|
1406
RLI Corp
RLI
$5.97B
| $491K | ﹤0.01% |
15,490
-5,580
| -26% | -$172K |
|
|
ESV
1407
DELISTED
Ensco Rowan plc
ESV
| $491K | ﹤0.01% |
27,961
+167
| +0.6% | +$3.68K |
|
|
CVSA
1408
Covista Inc
CVSA
$4.3B
| $490K | ﹤0.01% |
10,305
-1,851
| -15% | -$86.6K |
|
1409
Biglari Holdings Class B
BH
$1.18B
| $490K | ﹤0.01% |
1,799
-264
| -13% | -$73.1K |
|
1410
Quaker Houghton
KWR
$2.67B
| $488K | ﹤0.01% |
3,292
-775
| -19% | -$117K |
|
1411
Myriad Genetics
MYGN
$502M
| $488K | ﹤0.01% |
16,498
+60
| +0.4% | +$2.03K |
|
|
DNB
1412
DELISTED
Dun & Bradstreet
DNB
| $487K | ﹤0.01% |
4,160
-9
| -0.2% | -$1.09K |
|
|
EV
1413
DELISTED
Eaton Vance Corp.
EV
| $485K | ﹤0.01% |
8,704
+661
| +8% | +$37.5K |
|
1414
SEI Investments
SEIC
$12.4B
| $484K | ﹤0.01% |
6,458
-36
| -0.6% | -$2.68K |
|
|
JHG
1415
DELISTED
Janus Henderson
JHG
| $483K | ﹤0.01% |
14,593
+2,902
| +25% | +$107K |
|
1416
Northwest Natural Holdings
NWN
$2.18B
| $483K | ﹤0.01% |
8,376
-122
| -1% | -$6.85K |
|
1417
Harley-Davidson
HOG
$2.66B
| $482K | ﹤0.01% |
11,237
-5,391
| -32% | -$258K |
|
1418
Western Union
WU
$2.58B
| $479K | ﹤0.01% |
24,920
-18,187
| -42% | -$365K |
|
|
PAY
1419
DELISTED
Verifone Systems Inc
PAY
| $479K | ﹤0.01% |
31,139
-113
| -0.4% | -$1.97K |
|
1420
National Presto Industries
NPK
$884M
| $477K | ﹤0.01% |
5,087
-582
| -10% | -$57.8K |
|
1421
Robert Half
RHI
$4.04B
| $477K | ﹤0.01% |
8,239
-6,511
| -44% | -$372K |
|
1422
Norwegian Cruise Line
NCLH
$9.74B
| $476K | ﹤0.01% |
8,978
-6,037
| -40% | -$343K |
|
1423
West Pharmaceutical
WST
$23.7B
| $476K | ﹤0.01% |
5,393
-148,772
| -97% | -$13.9M |
|
1424
Ezcorp Inc
EZPW
$1.85B
| $475K | ﹤0.01% |
36,009
-5,335
| -13% | -$68.1K |
|
1425
Fortinet
FTNT
$110B
| $475K | ﹤0.01% |
44,300
-5,115
| -10% | -$49.8K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.